Oncopharmpod
May Approvals, More Questions
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:00
- Mas informaciones
Informações:
Sinopsis
Running through updated FDA approvals from this month (ivosidenib, T-DM1, ramucirumab, avelumab/axitinib, & venetoclax/obinutuzumab) and how these approvals raise more questions.
